These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 26782731)
1. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Hu J; Wang J; Wang G; Yao Z; Dang X Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731 [TBL] [Abstract][Full Text] [Related]
2. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Gang W; Jie WJ; Ping ZL; Ming du S; Ying LJ; Lei W; Fang Y Expert Opin Drug Deliv; 2012 Jun; 9(6):599-613. PubMed ID: 22607534 [TBL] [Abstract][Full Text] [Related]
3. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Song S; Mao G; Du J; Zhu X Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878 [TBL] [Abstract][Full Text] [Related]
5. Liposomal temozolomide drug delivery using convection enhanced delivery. Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727 [TBL] [Abstract][Full Text] [Related]
6. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment. Peng Y; Huang J; Xiao H; Wu T; Shuai X Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129 [TBL] [Abstract][Full Text] [Related]
7. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells. Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment. Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097 [TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
10. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316 [TBL] [Abstract][Full Text] [Related]
11. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide. Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212 [TBL] [Abstract][Full Text] [Related]
12. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. Wang G; Wang JJ; Chen XL; Du L; Li F J Control Release; 2016 Aug; 235():276-290. PubMed ID: 27242199 [TBL] [Abstract][Full Text] [Related]
13. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier. Yuan BO; Zhao Y; Dong S; Sun Y; Hao F; Xie J; Teng L; Lee RJ; Fu Y; Bi YE Anticancer Res; 2019 Jan; 39(1):237-243. PubMed ID: 30591464 [TBL] [Abstract][Full Text] [Related]
15. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model. Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431 [TBL] [Abstract][Full Text] [Related]
16. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Wang G; Wang JJ; Yang GY; Du SM; Zeng N; Li DS; Li RM; Chen JY; Feng JB; Yuan SH; Ye F Int J Nanomedicine; 2012; 7():271-80. PubMed ID: 22275840 [TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-glioma effect of a coloaded nano-drug delivery system. Xu H; Jia F; Singh PK; Ruan S; Zhang H; Li X Int J Nanomedicine; 2017; 12():29-40. PubMed ID: 28031711 [TBL] [Abstract][Full Text] [Related]
18. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133 [TBL] [Abstract][Full Text] [Related]